Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thrombocythemia, Essential × Flow Cytometry × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Follicular 7 Lymphoma, B-Cell, Marginal Zone 7 Congenital Abnormalities 7 Multiple Myeloma 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, Mantle-Cell 6 Leukemia, Myeloid, Acute 6 Leukemia 6 Sezary Syndrome 5 Myelodysplastic Syndromes 5 Mycosis Fungoides 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma 5 Burkitt Lymphoma 5 Waldenstrom Macroglobulinemia 4 Myeloproliferative Disorders 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Extranodal NK-T-Cell 4 Lung Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Blast Crisis 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Leukemia, Myeloid, Chronic-Phase 3

Interventions

fludarabine phosphate 13 Whole-Body Irradiation 7 Mycophenolic Acid 7 Peripheral Blood Stem Cell Transplantation 6 Cyclophosphamide 6 Busulfan 6 Cyclosporine 5 Tacrolimus 4 Antilymphocyte Serum 4 fludarabine 3 Methotrexate 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 ruxolitinib 2 givinostat hydrochloride 2 givinostat 2 Melphalan 2 Etoposide 2 Carboplatin 2 veliparib 1 thymoglobulin 1 sonidegib 1 pomalidomide 1 peginterferon alfa-2a 1 bomedemstat 1 anagrelide 1 Topotecan 1 Thiotepa 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡